GIC Sub-Industry »Biotechnology« (14)

Filter by Size, Price, EPS, Revenue, Debt, Returns and many other Dividend and Fundamental Data.

Results 14 matches
SYMBOL SUB-INDUSTRY MKT CAP VRT SIGNAL SAFETY RS DIV. YIELD
ABBV NYSE
AbbVie		 Biotechnology Immunology, Oncology, Aesthetics, Neuroscience 509B 64 1.56 64 91 2.9%
AMGN NASDAQ
Amgen		 Biotechnology Autoimmune, Oncology, Cardiovascular, Hematology 249B 70 1.24 73 90 2.7%
GILD NASDAQ
Gilead Sciences		 Biotechnology HIV Antivirals, Hepatitis Antivirals, Cell 208B 64 0.72 71 88 2.4%
REGN NASDAQ
Regeneron Pharmaceuticals		 Biotechnology Ophthalmology, Immunology, Oncology, Cardiology 93.4B 70 2.70 91 90 0.5%
LONN SW
Lonza		 Biotechnology Biologics, Bioconjugates, Cell Therapy, mRNA 55.6B 58 1.38 87 87 1.1%
HLN NYSE
Haleon		 Biotechnology Oral Care, Dietary Supplements, Respiratory Care 40.2B 48 -0.70 76 22 2.0%
ERF PA
Eurofins Scientific SE		 Biotechnology Agroscience Services, Clinical Diagnostics 16.9B 56 1.12 61 94 1.2%
BIM PA
Biomerieux		 Biotechnology Diagnostic Instruments, Culture Media 12.8B 52 0.47 80 74 1.4%
ALK-B CO
ALK-Abelló		 Biotechnology Immunotherapy Tablets, enaline Autoinjectors 8.15B 64 0.30 91 72 0.8%
DIA MI
DiaSorin S.p.A.		 Biotechnology Immunoassays, Molecular Testing, Infectious 4.53B 64 0.14 85 82 1.9%
INDV NASDAQ
Indivior Ordinary Shares		 Biotechnology Extended-Release Injections, Sublingual Films 4.28B 52 -0.65 54 27 28.7%
BIOA-B ST
BioArctic (publ)		 Biotechnology Antibodies, Lecanemab, Neurodegenerative 2.76B 41 -0.26 76 46 0.6%
PHM MC
Pharma Mar S.A.		 Biotechnology Antineoplastics, RNAi Therapeutics 1.25B 42 -0.58 70 14 1.2%
BTX NYSE
BlackRock Technology		 Biotechnology Technology Equity, Private Equity, Closed-End 872M 25 -0.47 37 64 8.4%
Technical
Structure
Fundamental
Dividend Yield & Growth
Dividend Consistency
Topics in GIC Sub-Industry »Biotechnology« (14)
  • Oncology
  • Immunology
  • Cell Therapy
  • Ophthalmology
  • Biologics
  • Immunoassays